Evidence map›Paper›PMID 35116128›Full record

ArticleNutrition research and practice2022

The efficacy and safety of

Ji Eun Jun, You-Cheol Hwang, Kyu Jeung Ahn, Ho Yeon Chung, Se Young Choung, In-Kyung Jeong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrition research and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Saskatoon berry (Food science and biotechnology · 2026
    Review
  2. Review
  3. Nutrients · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ji Eun JunDepartment of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Korea.ORCID https://orcid.org/0000-0002-7204-4913
You-Cheol HwangDepartment of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Korea.ORCID https://orcid.org/0000-0003-4033-7874
Kyu Jeung AhnDepartment of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Korea.ORCID https://orcid.org/0000-0002-4648-3605
Ho Yeon ChungDepartment of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Korea.ORCID https://orcid.org/0000-0002-4529-8280
Se Young ChoungDepartment of Preventive Pharmacy and Toxicology, Department of Life and Nanopharmaceutical Sciences of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0000-0001-7619-6263
In-Kyung JeongDepartment of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul 05278, Korea.ORCID https://orcid.org/0000-0001-7857-546X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesThe extract from SUBJECTS/

methodsA 12-week, double blind, placebo-controlled and randomized trial included a total of 74 adults, and they were assigned to the placebo group (n = 38) or 700 mg/day of

resultsAfter 12 weeks of treatment, the hemoglobin A1c (HbA1c) level significantly decreased in the

conclusionsSupplementation with

trial registrationClinical Research Information Service Identifier: KCT0004672.

Indexed as

functional foodglucosehypertensionMetabolic syndrome

Identifiers

PMID35116128
PMCPMC8784258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.